Skip to content

Resting myocardial contrast-enhanced Echocardiography model for diagnosis coronary heart disease

Resting myocardial contrast-enhanced echocardiography model for diagnosis coronary heart disease

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200061731
Enrollment
Unknown
Registered
2022-07-01
Start date
2022-08-01
Completion date
Unknown
Last updated
2023-04-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronary Heart Disease

Interventions

Gold Standard:Single Photon Emission Computed Tomography,SPECT
the&#32
cut-off&#32
diagnostic&#32
and&#32
of&#32
MCE&#32
to&#32

Sponsors

The Sixth Medical Center of PLA General Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. No SonoVue contrast agent allergic history; 2. Those who have a definite history of coronary heart disease or clinically suspected CHD and intend to undergo myocardial SPECT; 3. Patients who know the research process, voluntarily participate in and sign the informed consent form; 4. Clear mind and can cooperate with inspection; 5. The age ranged from 18 to 70 years.

Exclusion criteria

Exclusion criteria: 1. Patients who are allergic to SonoVue contrast agent; 2. Patients with congenital heart disease and severe pulmonary hypertension; 3. Heart failure and ventricular arrhythmia; 4. Patients with pulmonary embolism and adult respiratory distress syndrome; 5. Pregnant women.

Design outcomes

Primary

MeasureTime frame
TP(time to peak intensity);T( time);PI(peak intensity);MBF(myocardial blood flow);

Countries

China

Contacts

Public ContactXin Li
18600310370@163.com+86 18600310370

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026